{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:55:12Z","timestamp":1790873712032,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203825"],"award-info":[{"award-number":["82203825"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.trsl.2026.09.009","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T04:29:33Z","timestamp":1789360173000},"page":"229-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Therapeutic Co-targeting of oxidative phosphorylation and pyrimidine synthesis restores gemcitabine response in pancreatic ductal adenocarcinoma"],"prefix":"10.1016","volume":"297","author":[{"given":"Wenhui","family":"Ouyang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zemin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8681-1239","authenticated-orcid":false,"given":"Shanying","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2026.09.009_bib0001","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA: Cancer J Clin"},{"key":"10.1016\/j.trsl.2026.09.009_bib0002","article-title":"The war on pancreatic cancer: progress and promise","volume":"20","author":"Ca","year":"2023","journal-title":"Nat rev Gastroenterol hepatol"},{"key":"10.1016\/j.trsl.2026.09.009_bib0003","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: a review","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2026.09.009_bib0004","article-title":"Neoadjuvant chemotherapy in pancreatic cancer","volume":"156","author":"T","year":"2021","journal-title":"JAMA surg"},{"issue":"Suppl 5","key":"10.1016\/j.trsl.2026.09.009_bib0005","doi-asserted-by":"crossref","first-page":"v7","DOI":"10.1093\/annonc\/mdj941","article-title":"Cellular pharmacology of gemcitabine","volume":"17","author":"Mini","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.trsl.2026.09.009_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216382","article-title":"Gemcitabine effects on tumor microenvironment of pancreatic ductal adenocarcinoma: special focus on resistance mechanisms and metronomic therapies","volume":"573","author":"Natu","year":"2023","journal-title":"Cancer Lett"},{"key":"10.1016\/j.trsl.2026.09.009_bib0007","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/CM9.0000000000002758","article-title":"Pancreatic ductal adenocarcinoma chemoresistance: From metabolism reprogramming to novel treatment","volume":"137","author":"Zhang","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.trsl.2026.09.009_bib0008","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1200\/JCO.22.01134","article-title":"Adjuvant Nab-Paclitaxel + gemcitabine in resected pancreatic ductal adenocarcinoma: results from a randomized, open-label, phase III Trial","volume":"41","author":"Tempero","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trsl.2026.09.009_bib0009","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.50756","article-title":"NALIRIFOX, FOLFIRINOX, and gemcitabine with Nab-paclitaxel as first-line chemotherapy for metastatic pancreatic cancer: a systematic review and meta-analysis","volume":"7","author":"Nichetti","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.trsl.2026.09.009_bib0010","article-title":"A metabolic vulnerability of pancreatic cancer","volume":"616","author":"Dj","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2026.09.009_bib0011","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cmet.2020.10.017","article-title":"Functional genomics in vivo reveal metabolic dependencies of pancreatic cancer cells","volume":"33","author":"Zhu","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.trsl.2026.09.009_bib0012","article-title":"YTHDC1-mediated augmentation of miR-30d in repressing pancreatic tumorigenesis via attenuation of RUNX1-induced transcriptional activation of Warburg effect","volume":"28","author":"Y","year":"2021","journal-title":"Cell death differ"},{"key":"10.1016\/j.trsl.2026.09.009_bib0013","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.7150\/thno.45124","article-title":"Endoplasmic Reticulum stress-dependent expression of ERO1L promotes aerobic glycolysis in Pancreatic Cancer","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.trsl.2026.09.009_bib0014","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","article-title":"Mitochondrial TCA cycle metabolites control physiology and disease","volume":"11","author":"Mart\u00ednez-Reyes","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2026.09.009_bib0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41388-020-01518-2","article-title":"Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma","volume":"40","author":"Nimmakayala","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.trsl.2026.09.009_bib0016","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nature13611","article-title":"Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function","volume":"514","author":"Viale","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2026.09.009_bib0017","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1126\/science.aaa1193","article-title":"Ribosome. The structure of the human mitochondrial ribosome","volume":"348","author":"Amunts","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.trsl.2026.09.009_bib0018","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41586-022-05621-0","article-title":"Principles of mitoribosomal small subunit assembly in eukaryotes","volume":"614","author":"Harper","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2026.09.009_bib0019","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nature12890","article-title":"Architecture of the large subunit of the mammalian mitochondrial ribosome","volume":"505","author":"Greber","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2026.09.009_bib0020","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/humu.21562","article-title":"Exome sequencing identifies MRPL3 mutation in mitochondrial cardiomyopathy","volume":"32","author":"Galmiche","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1016\/j.trsl.2026.09.009_bib0021","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/ejhg.2010.214","article-title":"Mutation in mitochondrial ribosomal protein MRPS22 leads to Cornelia de Lange-like phenotype, brain abnormalities and hypertrophic cardiomyopathy","volume":"19","author":"Smits","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.trsl.2026.09.009_bib0022","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/jmg.2007.053116","article-title":"Antenatal mitochondrial disease caused by mitochondrial ribosomal protein (MRPS22) mutation","volume":"44","author":"Saada","year":"2007","journal-title":"J Med Genet"},{"key":"10.1016\/j.trsl.2026.09.009_bib0023","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41467-018-07922-3","article-title":"The mitochondrial type IB topoisomerase drives mitochondrial translation and carcinogenesis","volume":"10","author":"Baechler","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2026.09.009_bib0024","article-title":"Multiomic analysis of lactylation and mitochondria-related genes in hepatocellular carcinoma identified MRPL3 as a new prognostic biomarker","volume":"14","author":"Xing","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.trsl.2026.09.009_bib0025","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1038\/s41388-024-03092-3","article-title":"N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance","volume":"43","author":"Ma","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.trsl.2026.09.009_bib0026","unstructured":"GEO Accession viewer https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE79886."},{"key":"10.1016\/j.trsl.2026.09.009_bib0027","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1080\/15548627.2022.2132686","article-title":"Impaired TFEB activation and mitophagy as a cause of PPP3\/calcineurin inhibitor-induced pancreatic \u03b2-cell dysfunction","volume":"19","author":"Park","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.trsl.2026.09.009_bib0028","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","article-title":"Cancer cell metabolism: Warburg and beyond","volume":"134","author":"Hsu","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2026.09.009_bib0029","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200924","article-title":"Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia","volume":"218","author":"Stuani","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2026.09.009_bib0030","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3390\/cells11040739","article-title":"Re-discovery of pyrimidine salvage as target in cancer therapy","volume":"11","author":"Walter","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.trsl.2026.09.009_bib0031","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41586-020-2475-6","article-title":"Mitochondrial ubiquinol oxidation is necessary for tumour growth","volume":"585","author":"Mart\u00ednez-Reyes","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2026.09.009_bib0032","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41556-023-01146-4","article-title":"De novo pyrimidine biosynthetic complexes support cancer cell proliferation and ferroptosis defence","volume":"25","author":"Yang","year":"2023","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.trsl.2026.09.009_bib0033","article-title":"High tide or low tide: the transport and metabolism of mitochondrial nucleotides","volume":"482","author":"MacVicar","year":"2025","journal-title":"Biochem J"},{"key":"10.1016\/j.trsl.2026.09.009_bib0034","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fphar.2019.00098","article-title":"Shortage of cellular ATP as a cause of diseases and strategies to enhance ATP","volume":"10","author":"Johnson","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.trsl.2026.09.009_bib0035","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1053\/j.gastro.2021.06.045","article-title":"Metabolic rewiring by loss of Sirt5 Promotes Kras-induced pancreatic cancer progression","volume":"161","author":"Hu","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2026.09.009_bib0036","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2026.09.009_bib0037","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2026.09.009_bib0038","article-title":"Targeting mitochondrial complex I overcomes chemoresistance in high OXPHOS pancreatic cancer","volume":"1","author":"Masoud","year":"2020","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.trsl.2026.09.009_bib0039","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1053\/j.gastro.2021.06.045","article-title":"Metabolic rewiring by loss of Sirt5 promotes Kras-induced pancreatic cancer progression","volume":"161","author":"Hu","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2026.09.009_bib0040","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ccell.2017.08.008","article-title":"MUC1 and HIF-1alpha signaling crosstalk induces anabolic glucose metabolism to impart gemcitabine resistance to pancreatic cancer","volume":"32","author":"Shukla","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trsl.2026.09.009_bib0041","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.7150\/ijbs.60473","article-title":"Inhibition of de novo pyrimidine synthesis augments Gemcitabine induced growth inhibition in an immunocompetent model of pancreatic cancer","volume":"17","author":"Phan","year":"2021","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.trsl.2026.09.009_bib0042","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1111\/cas.15962","article-title":"Increased mitochondria are responsible for the acquisition of gemcitabine resistance in pancreatic cancer cell lines","volume":"114","author":"Masuo","year":"2023","journal-title":"Cancer Sci"},{"key":"10.1016\/j.trsl.2026.09.009_bib0043","unstructured":"M.D. Anderson Cancer Center (2025). A Phase 1b study of gemcitabine and Nab-paclitaxel in combination with IM156 in patients with advanced pancreatic cancer. (clinicaltrials.gov)."},{"key":"10.1016\/j.trsl.2026.09.009_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109024","article-title":"Inhibition of mitochondrial translation suppresses glioblastoma stem cell growth","volume":"35","author":"Sighel","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.trsl.2026.09.009_bib0045","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/s41419-021-04370-8","article-title":"MRPS31 loss is a key driver of mitochondrial deregulation and hepatocellular carcinoma aggressiveness","volume":"12","author":"Min","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.trsl.2026.09.009_bib0046","unstructured":"UCSC Xena https:\/\/xenabrowser.net\/datapages\/?dataset=TCGA.PAAD.sampleMap%2FHiSeqV2&host=https%3A%2F%2Ftcga.xenahubs.net&removeHub=https%3A%2F%2Fxena.treehouse.gi.ucsc.edu%3A443."},{"key":"10.1016\/j.trsl.2026.09.009_bib0048","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.trsl.2026.09.009_bib0049","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426001957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426001957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:56:00Z","timestamp":1790870160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524426001957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":48,"alternative-id":["S1931524426001957"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2026.09.009","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Co-targeting of oxidative phosphorylation and pyrimidine synthesis restores gemcitabine response in pancreatic ductal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2026.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}